WHO recommends strengthening lab services to meet a goal of testing 70% of women by 2030.

In other labs’ experience, what is the best methodology for measuring voriconazole and posaconazole? All respondents say that they use LC-MS/MS for TDM of these drugs, especially since LC-MS/MS allows you to build a platform that can easily be expanded to incorporate other drugs in the future. There is also a good immunoassay for voriconazole, but no one is aware of an immunoassay for posaconazole.

Instead of performing the labor-intensive assays for neutralizing SARS-CoV-2 antibodies, labs might be able to predict the presence of neutralizing antibodies based on automated serology test results instead.